
CA 27-29: A <a href="https://www.medicinenet.com/tumor_grade/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">tumor</a> marker similar to the CA 15-3 that is found in the blood of most <a href="https://www.medicinenet.com/breast_cancer_facts_stages/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">breast cancer</a> patients. CA 27-29 levels may be used in conjunction with other procedures (such as mammograms and measurements of other tumor marker levels) to check for recurrence in women previously treated for stage II and stage III <a href="https://www.medicinenet.com/breast_anatomy/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">breast</a> <a href="https://www.medicinenet.com/cancer/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">cancer</a>. 
CA 27-29 levels can also be elevated by cancers of the colon, stomach, kidney, lung, ovary, pancreas, uterus, and liver. First trimester <a href="https://www.medicinenet.com/pregnancy/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">pregnancy</a>, <a href="https://www.medicinenet.com/endometriosis/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">endometriosis</a>, <a href="https://www.medicinenet.com/ovarian_cysts/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">ovarian cysts</a>, benign breast disease, kidney disease, and <a href="https://www.medicinenet.com/liver_disease/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">liver disease</a> are noncancerous conditions that can also elevate CA 27-29 levels. 